CDH Investments
鼎晖投资
elsewhere's corpus does not cover CDH Investments. The retrieved materials mention C&D Emerging Investment , but no profile or identifying information about CDH Investments appears in the bundle.
AI-generated — may contain errors, please verify.
Coverage
"Zhongsheng Quanpeptide" Raises Over 300 Million Yuan in Series C Funding to Accelerate Global Expansion of Peptide-Based Innovative Drugs
It has secured multiple international partnerships with MNCs including Novartis and Eli Lilly and Company.
高榕创投·5Y News | Syneron Bio Closes $150 Million Series B Round
Syneron Bio today announced the completion of its Series B funding round.
五源资本·Yunqi Capital | Lead Series A investor Neolix raises over $600 million in Series D, with Yunqi Capital continuing to increase its stake
Accompanying the World's Largest L4 RoboVan Supplier in Its Continuous Evolution
云启资本·Exclusive | Luminous Sail Tech Raises 130 Million RMB in Three Months, with CATL Co-founder, Shokz, and Goertek Joining
The age of warring gods is back.
暗涌Waves·Where Are the Bold State Investors?
Breaking Down the Most Active Local State-Owned Capital.
暗涌Waves·The CVC-Qiao Jiangnan Buyout: Zhang Lan in the Spotlight, Public Opinion in the Shadows | Mega M&A
Who actually owes whom?
暗涌Waves·2024, When Everyone Stands at a Crossroads: 96 Investors' Decisions
Deciding is easy. Waiting is hard.
暗涌Waves·Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
暗涌Waves·Countless Lies About M&A in China, and One Truth
All we hear are footsteps on the stairs, but no one ever comes down.
暗涌Waves·The Alibaba investment executive who bet big on Kimi has left, and she sent off her departure with a rock song
"To be part of the wave can't stop."
暗涌Waves·If wisdom lacks the courage of execution, it is all in vain | 5Y News Monthly
The big news from last month.
五源资本·5Y News | 5Y Capital Portfolio Company ReviR Therapeutics Raises $30 Million in Series A Funding
Continuing to advance "oral gene therapy" through AI+RNA.
五源资本·Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
线性资本·WeLing Medical Completes Angel Plus Round to Advance Fully Implantable Medical-Grade Brain-Computer Interface System
Accelerating the clinical translation of brain-computer interface technology.
高榕创投·A Clever Exit Move: Turning 180 Million in Three Years
What "divine" new money-making method?
暗涌Waves·Conversations with 29 Tech Investors: There Are Treasures, But No Treasure Map
Investing in tech is definitely the right call, but consensus remains scarce.
暗涌Waves·Allen Luo and Zheng Gang: Let the Law Be the Law, and Let Emotions Be Emotions
A story about a VC-founder relationship hitting rock bottom.
暗涌Waves·Yinjia Biotech Closes Nearly RMB 100 Million Series A Round to Accelerate Buildout of Upstream Core Protein Ingredient Synthetic Biology Platform
Staying true to our mission as "protein craftsmen."
高榕创投·Capital O Closes First Fund, Post-90s GP Enters the Stage
Technological breakthroughs deserve more attention than market turbulence.
暗涌Waves·We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
暗涌Waves·Buyouts in China: A "Boy Who Cried Wolf" Fable
After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?
暗涌Waves·Robots, AI, and Simulation Technologies Accelerate Industrial Adoption | Rongbao · June
Technology drives industrial transformation.
高榕创投·Style3D Completes Nearly $100 Million Pre-B+ Round to Build Digital Fashion Infrastructure
Building out new digital infrastructure and accelerating overseas expansion.
高榕创投·Investors in the Wheat Field
A Nerve-Ending-Style Descent into the Investment World: Into the Fields and Countryside.
暗涌Waves·Global SaaS, New Brands, and Biopharma Companies Close New Funding Rounds | Rongbao · February
The vitality of spring.
高榕创投·Global E-commerce SaaS Platform Dianxiaomi Closes $100 Million Series C, Now Serving Over 1.2 Million Merchants Worldwide
Helping global e-commerce sellers boost efficiency and core competitiveness.
高榕创投·February: When the Tiger Roars, the Wind Rises | 5Y News Monthly
The big news from last month.
五源资本·5Y News | AI+RNA Startup ReviR Therapeutics Closes Tens of Millions of Dollars in Pre-A Round
Using AI algorithms and gene technology to drive targeted RNA drug development.
五源资本·Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
高榕创投·3 Biopharma Companies Raise Over 1 Billion Yuan Combined | FreeS Family Funding News · October–November
Firmly bullish on the development of biomedical innovation in China
峰瑞资本·Yinjia Biotech Closes Pre-A Round, Advancing Its High-End Protein Platform to New Heights
Build a leading domestic "protein artisan" platform.
高榕创投·Rongbao · June | BOSS Zhipin and Dingdong Maicai successfully go public; medical, industrial upgrade, and chip companies close new funding rounds
Xingji, Dongjing Yiwan, Qitan Technology, and other companies have completed new funding rounds.
高榕创投·Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
高榕创投·Gaorong News · December | Gaorong Ventures Named Among "China's Top 3 Best VC Funds of 2019," Ronghui "Youth Innovation Camp" Concludes
The future is bright.
高榕创投·
